GSK plc (GSK) 13F filing lists 13 U.S. positions worth over $602M

Rhea-AI Filing Summary

GSK plc, as an institutional investment manager, filed a Form 13F Holdings Report covering its U.S.-reportable securities portfolio. The report lists 13 individual holdings with a combined Form 13F information table value of 602,220,442 dollars. The filing shows 0 other included managers, indicating GSK plc alone is responsible for this report.

Key Figures

Form 13F information table value total: 602,220,442 Form 13F information table entry total: 13 Number of other included managers: 0

3 metrics

Form 13F information table value total 602,220,442 Aggregate value of reportable holdings, rounded to the nearest dollar

Form 13F information table entry total 13 Number of individual holdings reported in the Form 13F information table

Number of other included managers 0 Count of other institutional managers sharing responsibility for this 13F report

Key Terms

Form 13F Holdings Report, Institutional Investment Manager, Form 13F Information Table

3 terms

Form 13F Holdings Report regulatory

"Report Type (Check only one.) X | 13F HOLDINGS REPORT."

Institutional Investment Manager regulatory

"The institutional investment manager filing this report"

Form 13F Information Table financial

"Form 13F Information Table Value Total"

FAQ

What did GSK (GSK) report in its latest Form 13F filing?

GSK plc reported a Form 13F Holdings Report listing 13 U.S.-reportable securities positions. The combined Form 13F information table value was 602,220,442 dollars, rounded to the nearest dollar, with no other managers included.

How many positions are in GSK (GSK)'s 13F portfolio?

GSK plc’s Form 13F shows 13 individual holdings. These positions are the securities that met the SEC’s 13F reporting thresholds and together comprise the company’s reportable U.S. portfolio for this filing period.

What is the total reported value of GSK (GSK)'s 13F holdings?

The Form 13F information table value total is 602,220,442 dollars. This figure represents the aggregate value of all reportable U.S. securities positions included in GSK plc’s 13F information table, rounded to the nearest dollar.

Does GSK (GSK) share this 13F report with other managers?

No. The filing lists 0 other included managers. This means GSK plc is the sole institutional investment manager responsible for the Form 13F report and the holdings it covers in this submission.

What type of 13F report did GSK (GSK) file?

GSK plc filed a 13F HOLDINGS REPORT. This designation indicates that all of GSK’s reportable holdings are included directly in this report, rather than being reported by, or shared with, other institutional investment managers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:33 PM Accepted by SEC EDGAR 08/13/2026 - 04:32 PM Learn about SEC filing dates

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 06-30-2026

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	GSK plc
Address:	79 NEW OXFORD STREET
	London, X0 WC1A 1DG
Form 13F File Number:	028-26280
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Victoria Whyte
Title:		Authorised Signatory for and on behalf of GSK plc
Phone:		44-77709-42658
Signature, Place, and Date of Signing:
/s/ Victoria Whyte			London, X0	08-13-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		13
	Form 13F Information Table Value Total:		602,220,442
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE